InvestSMART

Xenitra Limited (ASX: XEN) - Announcements

- Current share price for XEN : $0.003

ASX company news and announcements for Xenitra Limited (XEN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Xenitra Limited (XEN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Xenitra Limited (XEN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Xenitra Limited (XEN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 Notice Under Section 708A 7 Sep 2026 6:51PM $0.003 $0.003 fallen by 16.67%
$12 Application for quotation of securities - XEN 7 Sep 2026 6:49PM $0.003 $0.003 fallen by 16.67%
$12 Notice Under Section 708A 1 Sep 2026 5:12PM $0.003 $0.003 fallen by 16.67%
$12 Application for quotation of securities - XEN 1 Sep 2026 4:56PM $0.003 $0.003 fallen by 16.67%
$12 Appendix 4G and Corporate Governance Statement 31 Aug 2026 6:44PM $0.003 $0.003 fallen by 16.67%
$12 Appendix 4E and Annual Report 31 Aug 2026 5:50PM $0.003 $0.003 fallen by 16.67%
$12 Proposed issue of securities - XEN 24 Aug 2026 9:57AM $0.003 $0.003 fallen by 16.67%
$12 Xenitra Raises $1.5m to Accelerate High-Margin Sales Growth 24 Aug 2026 9:57AM $0.003 $0.003 fallen by 16.67%
$12 Trading Halt 20 Aug 2026 9:37AM $0.003 $0.003 fallen by 16.67%
$12 $5m Offtake Agreement Expands OTC-Medicine Business 18 Aug 2026 9:47AM $0.004 $0.003 fallen by 28.57%
$12 Investor Presentation 30 Jul 2026 11:24AM $0.003 $0.003 fallen by 16.67%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2026 8:30AM $0.003 $0.003 fallen by 0%
$12 Investor Webinar 28 Jul 2026 8:40AM $0.003 $0.003 fallen by 16.67%
$12 $12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL 27 Jul 2026 8:55AM $0.003 $0.003 fallen by 0%
$12 Xenitra Investor Webinar 10 Jun 2026 9:31AM $0.003 $0.003 fallen by 0%
$12 $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks 4 Jun 2026 9:08AM $0.003 $0.003 fallen by 16.67%
$12 XEN Appointed as Exclusive Biomiq Skincare China Distributor 2 Jun 2026 8:23AM $0.003 $0.003 fallen by 0%
$12 Notice Under Section 708A 19 May 2026 4:34PM $0.003 $0.003 fallen by 16.67%
$12 Application for quotation of securities - XEN 19 May 2026 4:31PM $0.003 $0.003 fallen by 16.67%
$12 Product sales of $500k in first month of OPAL token launch 14 May 2026 9:19AM $0.003 $0.003 fallen by 16.67%
$12 Investor Presentation 7 May 2026 10:08AM $0.003 $0.003 fallen by 16.67%
$12 Proposed issue of securities - XEN 7 May 2026 9:21AM $0.004 $0.003 fallen by 37.50%
$12 $1.25m Raised to Support Next Phase of Growth 7 May 2026 9:21AM $0.004 $0.003 fallen by 37.50%
$12 Trading Halt 5 May 2026 10:49AM $0.004 $0.003 fallen by 37.50%
$12 Pause in Trading 5 May 2026 9:54AM $0.004 $0.003 fallen by 37.50%

1 - 25 of 94 results

Page 1 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.